Kymera Therapeutics Stock Forecast

Stock Price Forecast

According to 24 analysts polled by S&P Global, Kymera Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $139.35. The average 1-year stock price forecast is 22.82% higher than the current stock price, while the lowest is $111 (-2.17%) and the highest is $180 (+58.65%).

Price Target: $139.35 (+22.82%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$111	$139.35	$139	$180
Change	-2.17%	+22.82%	+22.51%	+58.65%

Analyst Ratings

The average analyst rating for Kymera Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	18	17	17	17	17	17
Buy	5	5	4	4	4	5
Hold	1	1	3	3	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	24	23	24	24	23	24

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $151	Buy	Maintains	$151	+33.09%	Oct 15, 2026
Geoff Meacham Citi	Citi	Buy Maintains $150	Buy	Maintains	$150	+32.21%	Oct 15, 2026
Thomas Deal Raymond James	Raymond James	Buy Initiates $140	Buy	Initiates	$140	+23.39%	Oct 8, 2026
Brian Cheng J.P. Morgan	J.P. Morgan	Buy Reiterates $140	Buy	Reiterates	$140	+23.39%	Sep 28, 2026
Biren Amin Piper Sandler	Piper Sandler	Buy Maintains $140	Buy	Maintains	$140	+23.39%	Sep 23, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

104.77M

from 39.21M

167.19%

from 39.21M

Revenue Next Year

40.65M

from 104.77M

-61.20%

from 104.77M

EPS This Year

-3.85

from -3.69

EPS Next Year

-5.10

from -3.85

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	72.83M	46.83M	78.59M	47.07M	39.21M	104.77M
Revenue Growth	114.00%	-35.71%	67.84%	-40.11%	-16.70%	167.19%
Operating Income	-100.53M	-161.26M	-165.53M	-256.71M	-345.54M	-432.01M
Net Income	-100.22M	-154.81M	-146.96M	-223.86M	-311.35M	-382.49M
EPS	-	-	-	-	-3.69	-3.85
Free Cash Flow	-	-	-	-	-234.34M	-352.03M
No. Analysts	-	-	-	-	-	23

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	139.0M
Avg	104.8M
Low	97.0M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	254.5%
Avg	167.2%
Low	147.4%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-3.13
Avg	-3.85
Low	-4.29

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-